{
    "URL": "https://doi.org/10.1371/journal.pntd.0004830",
    "Published": "July 26, 2016",
    "Subject_Areas": [
        "Cytokines",
        "Dengue fever",
        "Cytokine therapy",
        "Fevers",
        "Dengue virus",
        "Vaccination and immunization",
        "Recombinant vaccines",
        "Viral vaccines"
    ],
    "Authors": {
        "Anke Harenberg": [
            "R&NCS Department, Sanofi Pasteur, Marcy l\u2019Etoile, France"
        ],
        "Aymeric de Montfort": [
            "R&NCS Department, Sanofi Pasteur, Marcy l\u2019Etoile, France"
        ],
        "Fr\u00e9d\u00e9rique Jantet-Blaudez": [
            "R&NCS Department, Sanofi Pasteur, Marcy l\u2019Etoile, France"
        ],
        "Matthew Bonaparte": [
            "Global Clinical Immunology Department, Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America"
        ],
        "Florence Boudet": [
            "R&NCS Department, Sanofi Pasteur, Marcy l\u2019Etoile, France"
        ],
        "Melanie Saville": [
            "Global Clinical Development, Sanofi Pasteur, Marcy l\u2019Etoile, Lyon, France"
        ],
        "Nicholas Jackson": [
            "Research and Development, Sanofi Pasteur, Lyon, France"
        ],
        "Bruno Guy": [
            "Research and Development, Sanofi Pasteur, Lyon, France"
        ]
    }
}